Can a PET scan and blood test predict hormone therapy failure in breast cancer?
NCT ID NCT06067503
First seen Apr 15, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study is for people with a certain type of advanced breast cancer (lobular) that is hormone receptor-positive. The goal is to find better ways to detect when the cancer becomes resistant to hormone therapy. Researchers will use special PET scans and blood tests to look for changes in cancer cells early in treatment. The study does not test a new treatment, but aims to improve how we monitor response to standard therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UW Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.